First participant dosed in a Phase 1 clinical evaluation of a fusion protein vaccine designed to provide ‘serotype-independent’ protection against disease caused by multiple Streptococcus pneumoniae serotypes BOSTON–(BUSINESS WIRE)–Vaccine development company Matrivax announces the start of its Phase 1 clinical study to assess the safety, tolerability, and immunogenicity of its lead pneumococcal disease vaccine candidate, … [Read more…]

Guy Wagner Named HGPII Steering Committee Chair NASHVILLE, Tenn.–(BUSINESS WIRE)–HealthTrust Performance GroupSM, a leading healthcare performance improvement company, supports ethical business standards and conduct in the healthcare supply chain as espoused in the 17th Annual Report of the Healthcare Group Purchasing Industry Initiative, or HGPII. In the report, HGPII acknowledges how HealthTrust has created greater … [Read more…]

Acquired Assets from LIVMOR, Extending Reach in Remote Monitoring and Detection with an Existing Cutting Edge FDA-Cleared Product, Halo+™ Atrial Fibrillation Detection System Partnered with Evolve Manufacturing to Build HeartBeam AIMIGo 12-Lead 3D Vector Electrocardiogram Device Received European Patent for HeartBeam AIMIGo Technology Initial FDA Submission of HeartBeam AIMIGo™, the Telehealth Solution, Projected for Q2 … [Read more…]

CAHmelia-203 in Adult Classic CAH Surpasses 50% Enrollment Private Placement Financing of $53.6 million in Gross Proceeds with Top-Tier Healthcare Investors Strategic Partnership and Exclusive Licensing Agreement with Kaken Pharmaceutical to Develop and Commercialize Tildacerfont for CAH in Japan Private Placement Proceeds and Kaken Upfront Payment Expected to Extend Cash Runway Into 1H 2025 SOUTH … [Read more…]

GROVE CITY, Ohio–(BUSINESS WIRE)–Horton Emergency Vehicles, a subsidiary of REV Group Inc., and a leader in ambulance safety, announces the launch of Horton Occupant Protection System™ (HOPS) featuring MBrace™, the first of its kind protection for first responders. MBrace is a patent-pending advanced airbag safety system designed specifically to protect emergency care providers inside the … [Read more…]

The target Prescription Drug User Fee Act (PDUFA) action date for a decision by the FDA is May 2023 NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) voted 16 to 1 that available data support the safety and effectiveness of PAXLOVID™ (nirmatrelvir … [Read more…]

BOSTON–(BUSINESS WIRE)–Tekla Life Sciences Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 20233. The renewal will … [Read more…]

BOSTON–(BUSINESS WIRE)–Tekla World Healthcare Fund (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year period ending July 14, 2023. The renewal will … [Read more…]

100% of proceeds to benefit local teens struggling with crisis and adversity IRVINE, Calif.–(BUSINESS WIRE)–TILLYS is proud to host its 16th Annual Charity Golf Tournament, SUPERHERO SCRAMBLE, benefiting Tilly’s Life Center (TLC) on April 24th at Mission Viejo Country Club. TLC is a 501(c)(3) nonprofit founded by TILLYS co-founder, Tilly Levine, whose mission is to … [Read more…]

Companies formally kick off relationship with launch of new eczema-focused video game CHICAGO–(BUSINESS WIRE)–Level Ex today announced it has partnered with Gladskin, the innovative international skincare brand, to create custom, interactive gaming experiences that educate and train medical professionals on the science of endolysin technology and Gladskin’s new product line, GladskinMD, which will be exclusively … [Read more…]